This statistic shows the sales value of the medications for dementia based on the insurance benefits claimed in South Korea from 2011 to 2016. In 2016, the sales of drug treatments for Alzheimer's disease in South Korea amounted to around 216 billion South Korean won.
Sales value of the medications for dementia based on the insurance benefits claimed in South Korea from 2011 to 2016 (in billion South Korean won)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 USD $39 USD / Month *
in the first 12 months
Professional Account
Full access
Corporate solution including all features.
* Prices do not include sales tax.
Statistics on Dementia and Alzheimer's disease in Europe
World overview
6
- Premium Statistic Global death rate - leading causes 2019
- Premium Statistic Number of dementia sufferers worldwide 2018-2050
- Premium Statistic Dementia care expenditure forecast worldwide 2018-2030
- Premium Statistic People with dementia worldwide by income class 2015-2050
- Premium Statistic Alzheimer's disease clinical trials success rate globally from 2008-2019, by phase
- Premium Statistic Number of active disease-modifying Alzheimer's drug trials globally in 2019, by phase
European focus
5
- Premium Statistic Prevalence rate of dementia in Europe in 2018, by country
- Premium Statistic Prevalence of dementia in Europe forecast for 2050, by country
- Premium Statistic Prevalence of dementia in Europe in 2019, by gender and age
- Premium Statistic Incidence of Alzheimer's disease in Europe 1990-2019
- Premium Statistic Incidence of Alzheimer's disease in Europe 1990-2019, by gender
Mortality and morbidity
8
- Premium Statistic Rate of mortality due to dementia in Europe in 2019, by country
- Premium Statistic Potential years of life lost due to dementia in Europe in 2019
- Premium Statistic Disability-adjusted life years due to Alzheimer's disease in Europe 1990-2019
- Premium Statistic Disability-adjusted life years due to Alzheimer's disease Europe 1990-2019, by gender
- Premium Statistic Years lived with disability due to Alzheimer's disease in Europe 1990-2019
- Premium Statistic Years lived with disability due to Alzheimer's disease in Europe 1990-2019, by gender
- Premium Statistic Potential years of life lost due to Alzheimer's disease in Europe in 2019, by country
- Premium Statistic Potential years of life lost due to Alzheimer's disease in Europe in 2019, by gender
Situation in specific countries
8
- Premium Statistic Number of people living with dementia in France 2018-2050
- Premium Statistic Number of people living with dementia in Germany 2018-2050
- Premium Statistic Number of people living with dementia in Italy 2018-2050
- Premium Statistic Number of people living with dementia in the Netherlands 2018-2050
- Premium Statistic Number of people living with dementia in the United Kingdom 2018-2050
- Premium Statistic Number of people living with dementia in Sweden in 2018-2050
- Premium Statistic Number of people living with dementia in Spain 2018-2050
- Premium Statistic Number of people living with dementia in Poland 2018-2050
Policies directed towards dementia
8
- Premium Statistic Dementia policies readiness and innovation index in Europe 2021. by country
- Premium Statistic Dementia early detection and diagnosis ratings in Europe 2021. by country
- Premium Statistic Access to dementia medical care ratings in Europe 2021. by country
- Premium Statistic Dementia policies assessment index in France 2021
- Premium Statistic Dementia policies assessment index in Germany 2021
- Premium Statistic Dementia policies assessment index in Italy 2021
- Premium Statistic Dementia policies assessment index in Spain 2021
- Premium Statistic Dementia policies assessment index in the United Kingdom 2021
Further related statistics
10
- Alzheimer's patient distribution in South Korea 2016, by age group
- Alzheimer's patient number South Korea 2013-2024
- Most common prescription drugs for prostatic hyperplasia South Korea 2016
- BPH outpatient prescription medicine sales in South Korea 2016, by age group
- Volume of the ten best-selling drugs in France 2015, by packaging
- Dementia caregivers opinions on stress and reward of their work in the U.S. in 2017
- Dementia caregivers' challenges of caregiving in the U.S. as of 2017
- Market share of U.S. cold medication brands in the U.S. 2014
- Sales share of cold sore medication brands in the U.S. 2019
- Leading lip balm vendors in the U.S. 2012, based on sales
Further Content: You might find this interesting as well
Statistics
- Alzheimer's patient distribution in South Korea 2016, by age group
- Alzheimer's patient number South Korea 2013-2024
- Most common prescription drugs for prostatic hyperplasia South Korea 2016
- BPH outpatient prescription medicine sales in South Korea 2016, by age group
- Volume of the ten best-selling drugs in France 2015, by packaging
- Dementia caregivers opinions on stress and reward of their work in the U.S. in 2017
- Dementia caregivers' challenges of caregiving in the U.S. as of 2017
- Market share of U.S. cold medication brands in the U.S. 2014
- Sales share of cold sore medication brands in the U.S. 2019
- Leading lip balm vendors in the U.S. 2012, based on sales
KHIDI. (February 6, 2018). Sales value of the medications for dementia based on the insurance benefits claimed in South Korea from 2011 to 2016 (in billion South Korean won) [Graph]. In Statista. Retrieved February 03, 2023, from https://www.statista.com/statistics/863772/south-korea-dementia-medicine-sales/
KHIDI. "Sales value of the medications for dementia based on the insurance benefits claimed in South Korea from 2011 to 2016 (in billion South Korean won)." Chart. February 6, 2018. Statista. Accessed February 03, 2023. https://www.statista.com/statistics/863772/south-korea-dementia-medicine-sales/
KHIDI. (2018). Sales value of the medications for dementia based on the insurance benefits claimed in South Korea from 2011 to 2016 (in billion South Korean won). Statista. Statista Inc.. Accessed: February 03, 2023. https://www.statista.com/statistics/863772/south-korea-dementia-medicine-sales/
KHIDI. "Sales Value of The Medications for Dementia Based on The Insurance Benefits Claimed in South Korea from 2011 to 2016 (in Billion South Korean Won)." Statista, Statista Inc., 6 Feb 2018, https://www.statista.com/statistics/863772/south-korea-dementia-medicine-sales/
KHIDI, Sales value of the medications for dementia based on the insurance benefits claimed in South Korea from 2011 to 2016 (in billion South Korean won) Statista, https://www.statista.com/statistics/863772/south-korea-dementia-medicine-sales/ (last visited February 03, 2023)
Sales value of the medications for dementia based on the insurance benefits claimed in South Korea from 2011 to 2016 (in billion South Korean won) [Graph], KHIDI, February 6, 2018. [Online]. Available: https://www.statista.com/statistics/863772/south-korea-dementia-medicine-sales/